FDA staff raised concerns that need to be addressed prior to potential human tests of artificial womb technology (AWT), a device that simulates a womb for extremely premature infants, as detailed in briefing documentsopens in a new tab or window released ahead of a Pediatric Advisory Committee meetingopens in a new tab or window next week.
AWT devices are intended to treat extremely premature infants, who have increased risks of mortality and morbidity
Komentarze (4)
najlepsze